Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,422 | 587 | 97.5% |
| Education | $293.74 | 3 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,695 | 92 | $0 (2024) |
| Lilly USA, LLC | $991.35 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $945.85 | 54 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $906.32 | 47 | $0 (2024) |
| PFIZER INC. | $826.31 | 43 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $691.54 | 30 | $0 (2024) |
| GENZYME CORPORATION | $621.27 | 29 | $0 (2024) |
| Galderma Laboratories, L.P. | $553.87 | 34 | $0 (2024) |
| LEO Pharma Inc. | $541.34 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $515.06 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,580 | 151 | PFIZER INC. ($369.88) |
| 2023 | $2,619 | 128 | AbbVie Inc. ($360.75) |
| 2022 | $1,887 | 97 | ABBVIE INC. ($369.99) |
| 2021 | $1,029 | 41 | Janssen Scientific Affairs, LLC ($235.67) |
| 2020 | $807.11 | 43 | AbbVie Inc. ($203.23) |
| 2019 | $1,419 | 69 | Celgene Corporation ($154.80) |
| 2018 | $401.55 | 24 | Janssen Biotech, Inc. ($57.51) |
| 2017 | $973.45 | 37 | AbbVie, Inc. ($199.21) |
All Payment Transactions
590 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.69 | General |
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Immunology | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Inflammation & Immunology | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Immunology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $45.22 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Immunology | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.38 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.39 | General |
| 11/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.96 | General |
| Category: Immunology | ||||||
| 11/20/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: Inflammation & Immunology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.58 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $61.14 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Inflammation & Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,122 | 1,650 | $244,594 | $83,338 |
| 2022 | 19 | 937 | 1,338 | $194,025 | $71,355 |
| 2021 | 19 | 822 | 1,128 | $149,030 | $59,652 |
| 2020 | 12 | 670 | 1,037 | $118,263 | $51,726 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 281 | $45,989 | $16,657 | 36.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 139 | 178 | $36,496 | $13,770 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 105 | $24,419 | $8,873 | 36.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 125 | 125 | $25,349 | $8,227 | 32.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 109 | 122 | $22,386 | $6,795 | 30.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 127 | 164 | $19,887 | $4,980 | 25.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 19 | $10,251 | $4,338 | 42.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 61 | 78 | $7,964 | $2,715 | 34.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 17 | 26 | $6,246 | $2,336 | 37.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 24 | 25 | $5,535 | $2,037 | 36.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 20 | $4,549 | $1,743 | 38.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 18 | $8,024 | $1,655 | 20.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 24 | 44 | $4,002 | $1,622 | 40.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 16 | $4,289 | $1,568 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,455 | $1,503 | 27.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 36 | 36 | $4,637 | $1,484 | 32.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 76 | 320 | $3,838 | $1,427 | 37.2% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 11 | 11 | $2,333 | $831.26 | 35.6% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 13 | 16 | $2,890 | $752.54 | 26.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 28 | $55.64 | $23.31 | 41.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 150 | 150 | $29,343 | $10,639 | 36.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 112 | 140 | $27,637 | $10,604 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 161 | $25,586 | $9,925 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 82 | $18,415 | $7,545 | 41.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 105 | 120 | $21,375 | $7,265 | 34.0% |
About Dr. Anna Edhegard, MD
Dr. Anna Edhegard, MD is a Dermatology healthcare provider based in Morganton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2009. The National Provider Identifier (NPI) number assigned to this provider is 1164657391.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Edhegard, MD has received a total of $11,716 in payments from pharmaceutical and medical device companies, with $2,580 received in 2024. These payments were reported across 590 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($11,422).
As a Medicare-enrolled provider, Edhegard has provided services to 3,551 Medicare beneficiaries, totaling 5,153 services with total Medicare billing of $266,072. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Morganton, NC
- Active Since 05/18/2009
- Last Updated 06/21/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164657391
Products in Payments
- DUPIXENT (Biological) $1,257
- TREMFYA (Drug) $1,094
- SKYRIZI (Biological) $897.47
- TALTZ (Drug) $883.17
- ILUMYA (Biological) $575.45
- Sotyktu (Drug) $515.06
- ADBRY (Biological) $469.96
- EUCRISA (Drug) $359.87
- CIBINQO (Drug) $349.93
- COSENTYX (Biological) $341.93
- Otezla (Drug) $315.82
- RINVOQ (Biological) $294.82
- Humira (Biological) $293.81
- Cimzia (Drug) $214.63
- VTAMA (Drug) $202.34
- SOOLANTRA (Drug) $181.44
- SILIQ (Drug) $169.33
- Enbrel (Biological) $164.86
- DORYX (Drug) $143.36
- ACZONE (Drug) $139.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.